This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Here's the Next Small-Cap Stock the Spec Money Will Chase

 DELAFIELD, Wis. (Stockpickr) -- Speculative money has returned to the markets with a vengeance in the small-cap arena, and it's hitting the tape across a number of sectors.

>>4 Stocks Under $10 in Breakout Territory

Just take a look at the performance of intellectual property player Spherix (SPEX - Get Report) on Tuesday. This stock exploded higher by 96% with massive upside volume after the U.S. Senate and Senate Judiciary Committee Chairman Patrick Leahy removed a patent reform bill from the committee's calendar due to lack of bipartisan support. Traders bought shares of SPEX with no hesitation, pushing the stock above a number of key overhead resistance levels at $1.86 to $1.99 a share with heavy upside volume flows. Volume on Tuesday registered 45.16 million shares, which is well above its three-month average action of 1.46 million shares.

Another small-cap stock that exploded higher on Tuesday was biotechnology player Prana Biotechnology (PRAN), which ripped to the upside by 21% with strong upside volume flows. This stock has been a favorite target of the short-sellers, with shares down a whopping 72% coming into that sharp spike higher yesterday. Shares of PRAN broke out on Tuesday above some key near-term overhead resistance levels at $1.72 to $1.75 a share with strong upside volume. Volume registered 5.86 million shares, which easily exceeded its three-month average volume of 1.96 million shares.

Another small-cap stock that has seen spec money push its shares sharply higher in recent trading sessions is India Globalization Capital (IGC - Get Report), which has exploded to the upside over the last month by 111%. This materials and infrastructure company in India and China has ripped to the upside from its May low of 63 cents per share to its recent 52-week high of $2.34 a share with strong upside volume flows. Most of that move was driven by the company's recent announcement that it will focus on the growing medical marijuana industry as an area of acquisition interest.

>>Must-See Charts: 5 Large-Cap Trades for All-Time Highs

If you're a small-cap speculative trader like I am, then the of action in these three stocks is exactly what you want to see. Spec money is flowing back into small-cap stocks, and the volume levels are very healthy. This spec money is hitting a number of sectors, but what I especially like to see is the money coming into the small-cap biotech stocks. That sector has been beaten down big in 2014, so it's nice to see that traders aren't afraid to take on size in that space once some of these names start moving.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
IGC $0.21 0.00%
MNGA $0.98 0.00%
PRAN $0.88 0.00%
SPEX $0.47 0.00%
AAPL $110.38 0.00%


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs